Want to see GRI full AI Analyst Report?
GRI Bio (GRI) Financial Statements
GRI Bio Financial Overview
GRI Bio's market cap is currently $3.34M. The company's EPS TTM is $-80.38; its P/E ratio is -0.04; GRI Bio has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Mar 24 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -4.00K | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -11.98M | $ -8.23M | $ -11.39M | $ -2.24M | $ -1.06M |
| EBITDA | $ -11.97M | $ -8.23M | $ -10.95M | $ -2.56M | $ -989.00K |
| Net Income | $ -11.96M | $ -8.21M | $ -13.04M | $ -3.22M | $ -1.56M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 8.23M | $ 5.03M | $ 1.81M | $ 9.00K | $ 90.00K |
| Total Assets | $ 8.67M | $ 5.74M | $ 2.96M | $ 383.00K | $ 218.00K |
| Total Debt | $ 71.00K | $ 119.00K | $ 14.00K | $ 673.00K | $ 3.61M |
| Net Debt | $ -8.16M | $ -4.91M | $ -1.79M | $ 664.00K | $ 3.52M |
| Total Liabilities | $ 2.66M | $ 1.71M | $ 2.70M | $ 2.01M | $ 4.94M |
| Stockholders' Equity | $ 6.01M | $ 4.03M | $ 259.00K | $ -1.63M | $ -4.72M |
| Cash Flow | |||||
| Free Cash Flow | $ -10.19M | $ -8.61M | $ -9.00M | $ -1.09M | $ -8.31M |
| Operating Cash Flow | $ -10.19M | $ -8.61M | $ -8.99M | $ -1.08M | $ -8.31M |
| Investing Cash Flow | $ -3.00K | $ 0.00 | $ -8.00K | $ -3.00K | $ -3.84M |
| Financing Cash Flow | $ 13.39M | $ 11.83M | $ 10.80M | $ 1.01M | $ 15.75M |
Currency in USD